Optimised Transcranial Magnetic Stimulation for the Treatment of Obsessive Compulsive Disorder

Monash University0 个研究点目标入组 49 人开始时间: 2019年1月8日最近更新: 2022年8月9日

适应症

试验速览

暂无简介。

•1.Age of 18 to 65 years inclusive?
•2.Does the patient have a primary diagnosis of Obsessive-Compulsive Disorder (OCD) according to the DSM-V criteria?
•3.Does the patient currently score between 17-31 (ie. Moderate to severe) on the Yale and Brown Obsessive Compulsive Scale (Y-BOCS)?
•** Please Note: completion of the Y-BOCS is not a required prerequisite for the Clinical Trial, but rather a gauge on the severity of symptoms that we require for participation. We will assess the patient on this measure as part of the clinical assessments. If you have not completed the Y-BOCS with the patient but they have moderate to severe OCD symptoms, please circle N/A.
•4.Has the patient had a diagnosis of OCD for a period greater than 12 months?
•5.Does the patient have the capacity to give informed consent to participate in the clinical trial?
•6.Will the patient be able to attend the Epworth Centre for Innovation in Mental Health (Mon-Fri) for 3 weeks?

•1.Does the patient have any contraindication to having a magnetic resonance imaging (MRI)?
•2.Does the patient have any contraindication to having transcranial magnetic stimulation (TMS)?
•3.Has the patient ever been diagnosed with a psychotic disorder?
•4.Has the patient ever been diagnosed with Bipolar I or II?
•5.Does the patient have any medical condition that would interfere with treatment?
•6.Has the patient’s pharmaceutical treatment changed in the past three months?
•7.Does the patient have Tourette’s syndrome?
•8.Has the patient ever suffered from a substance abuse disorder or alcohol/drug misuse?
•9.Is the participant pregnant or planning to become pregnant during the duration of the trial?

发起方